thiostrepton
A heterodetic cyclic peptide, in which the cyclisation step involves a formal lactonisation between the carboxy group of a quinaldic acid-based residue and a secondary alcohol. An antibiotic that inhibits bacterial protein synthesis. Also acts as an antitumor agent.
Classification
ribosomally synthesized and post-translationally modified peptide antibioticsARO:3009656
-
CHEBI:24533 - ribosomally synthesized and post-translationally modified peptide antibiotics
ARO:3009656
Chemical structure
| Molecular formula | C72H85N19O18S5 |
|---|---|
| Charge | 0 |
| Average mass | 1664.922 Da |
| Monoisotopic mass | 1663.49235 Da |
| Source | ChEBI |
| InChIKey | NSFFHOGKXHRQEW-AIHSUZKVSA-N |
[H][C@]12N=C(c3nc(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)cs3)CC[C@@]13NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)N[C@@H]1C=Cc4c([C@H](C)O)cc(nc4[C@H]1O)C(=O)O[C@H](C)[C@H](NC(=O)c1csc(n1)[C@H]([C@](C)(O)[C@@H](C)O)NC(=O)[C@H]1CSC(=N1)/C(=C/C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c1csc3n1)c1nc2cs1
InChI=1S/C72H85N19O18S5/c1-14-26(3)47-63(105)78-30(7)57(99)75-28(5)56(98)76-31(8)58(100)91-72-19-18-40(66-85-43(22-111-66)59(101)77-29(6)55(97)74-27(4)54(73)96)81-52(72)42-21-112-67(83-42)49(34(11)109-69(107)41-20-37(32(9)92)36-16-17-39(79-47)51(95)50(36)80-41)89-60(102)44-24-113-68(86-44)53(71(13,108)35(12)94)90-62(104)45-23-110-65(84-45)38(15-2)82-64(106)48(33(10)93)88-61(103)46-25-114-70(72)87-46/h15-17,20-22,24-26,30-35,39,45,47-49,51-53,79,92-95,108H,4-6,14,18-19,23H2,1-3,7-13H3,(H2,73,96)(H,74,97)(H,75,99)(H,76,98)(H,77,101)(H,78,105)(H,82,106)(H,88,103)(H,89,102)(H,90,104)(H,91,100)/b38-15-/t26-,30-,31-,32-,33+,34+,35+,39+,45+,47-,48-,49-,51-,52+,53+,71+,72+/m0/s1
Also called
- Thiostrepton
- bryamycin
- gargon
- thiactin
- thiostrepton A
Cross-references
- thiostrepton
ARO:3000686 - cas:1393-48-2
- kegg.compound:C12054
- knapsack:C00000753
- metacyc.compound:CPD-13481
- reaxys:7390758
- vsdb:3007
- chembl:CHEMBL1236460
- pubchem.compound:16129666
Drug registries
Patents and articles
Activity roles
- antibacterial drug
CHEBI:36047
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3000686 |
thiostrepton | antibioticmech:aro-a8c48c531c |
2026-08-30 |
| CHEBI | CHEBI:29693 |
thiostrepton | antibioticmech:chebi-c0376c1060 |
2026-08-30 |
Molecular targets
50S ribosomal subunit P-site RIBOSOMAL_SUBUNIT DIRECT_BINDING_TARGET
70S ribosome GTPase-associated center RIBOSOMAL_SUBUNIT MEASURED_TARGET_ASSOCIATION
Mechanism summary
- Mode of action
- PROTEIN_SYNTHESIS_INHIBITION host shared target
Resistance mechanisms
ANTIBIOTIC_TARGET_ALTERATION 1
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| tsnR | ARO:3003060 | — |
Record-level evidence
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO, CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
REVIEWED
Verified exact ChEBI/CARD identity, structure, roles, class, and retained CARD target/resistance provenance; curator-confirmed protein-synthesis inhibition and added the measured ribosomal GTPase-center association.
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories